Skip to main content

GSI 9883 Pill: brown, capsule/oblong, 15mm

Generic Name: bictegravir/emtricitabine/tenofovir alafenamide

The pill with imprint GSI 9883 (Brown, Capsule/Oblong, 15mm) has been identified as Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg and is used for HIV Infection. It belongs to the drug class antiviral combinations and is not a controlled substance.

Images for GSI 9883

Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg GSI 9883
Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg GSI 9883
Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg GSI 9883

Biktarvy

Generic Name
bictegravir/emtricitabine/tenofovir alafenamide
Imprint
GSI 9883
Strength
bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg
Color
Brown
Size
15.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Antiviral combinations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gilead Sciences, Inc.
National Drug Code (NDC)
61958-2501
Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, magnesium stearate, water, titanium dioxide, magnesium silicate, ferrosoferric oxide, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.